This is an old revision of this page, as edited by 41.238.20.188 (talk) at 17:18, 6 January 2011 (→Mechanism of action). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 17:18, 6 January 2011 by 41.238.20.188 (talk) (→Mechanism of action)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff) This article is about the pharmaceutical agent 'dinoprost'. For the drug 'dinoprostone', see Prostaglandin E2. Pharmaceutical compoundClinical data | |
---|---|
Routes of administration | Intravenous (to induce labor), intra-amniotic (to induce abortion) |
ATC code | |
Pharmacokinetic data | |
Elimination half-life | 3 to 6 hours in amniotic fluid, less than 1 minute in blood plasma |
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
DrugBank | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.209.720 |
Chemical and physical data | |
Formula | C20H34O5 |
Molar mass | 354.48 g/mol g·mol |
3D model (JSmol) | |
SMILES
| |
(verify) |
Prostaglandin F2α (PGF2α in prostanoid nomenclature) is pharmaceutically termed Dinoprost (INN) is a naturally-occurring prostaglandin used in medicine to induce labor and as an abortifacient.
In domestic mammals, it is produced by the uterus when stimulated by oxytocin, in the event that there has been no implantation during the follicular phase. It acts on the corpus luteum to cause luteolysis, forming a corpus albicans and stopping the production of progesterone. Action of PGF2α is dependent on the number of receptors on the corpus luteum membrane.
The PGF2α isoform 8-iso-PGF2α is significantly increased endometriosis, being a potential causative links in endometriosis-associated oxidative stress.
Mechanism of action
Further information: ]PGF2α acts by binding to the prostaglandin F2α receptor.it is also commercially available as (Enzaprost)
References
- Attention: This template ({{cite doi}}) is deprecated. To cite the publication identified by doi:10.1016/j.fertnstert.2009.01.141, please use {{cite journal}} (if it was published in a bona fide academic journal, otherwise {{cite report}} with
|doi=10.1016/j.fertnstert.2009.01.141
instead.
Eicosanoids | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Precursor | |||||||||||||||
Prostanoids |
| ||||||||||||||
Leukotrienes (LT) |
| ||||||||||||||
Eoxins (EX) |
| ||||||||||||||
Nonclassic |
| ||||||||||||||
By function |
Uterotonics/labor inducers/oxytocics (G02A) | |||||
---|---|---|---|---|---|
Cervical ripening |
| ||||
Contraction induction | |||||
|
This medical article is a stub. You can help Misplaced Pages by expanding it. |